JPRN-UMIN000013333
Recruiting
Phase 1
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer. - PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.
agoya City West Medical Center0 sites35 target enrollmentMarch 4, 2014
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- advanced non-squamous non-small cell lung cancer
- Sponsor
- agoya City West Medical Center
- Enrollment
- 35
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Hemorrhagic Diathesis, coagulopathy (2\) Presence of cardiovascular invasion (3\) Presence of any tumor with cavitation (4\) Presence of significant interstitial lung disease or lung fibrosis (5\) Uncontrolled intercurrent illness (eg. hypertension, diabetes mellitus, gastro\- intestinal fistula, symptomatic congestive heart failure, unstable angina pectoris, serious cardiac arrhythmia) (6\) Ongoing/active infection (7\) Arterial thrombotic events or significant vascular disease (8\) Uncontrolled gastric ulcer (9\) Gastrointestinal perforation within the past 12 months (10\) Prior malignancy (11\) Uncontrolled pleural effusion or ascites (12\) Clinically significant pericardial effusion (13\) Hypersensitivity history for test drugs (14\) Pregnancy or breast\-feeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
Recruiting
Phase 1
Phase I/II study of carboplatin and nab-paclitaxel and concurrent thoracic radiation for patients with Locally advanced NSCLCJPRN-UMIN000020359Gunma University50
Completed
Phase 2
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426)on small cell lung cancerJPRN-UMIN000019458PO Thoracic Oncology Research Group42
Completed
Phase 2
Phase II study of Carboplatin + nab-Paclitaxel followed by nab-Paclitaxel with chemotherapy naive advanced Non- Small Cell Lung CancerChemotherapy naive non-small cell lung cancerJPRN-UMIN000015144Fukuoka University School of Medicine40
Completed
Phase 1
A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancernon small cell lung cancerJPRN-UMIN000013223Kochi University12